Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 17, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - August 17, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/18/17 - Beauty Supplements Market by Type, Size, Share, Growth & Forecast 2021
Zion Market Research, the market research group announced the analysis report titled' Beauty Supplements Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2015 2021' Sarasota, FL 07/17/2017 Supplements consist of products that are used to enhance, improve, and offer support to any kind of deficiency in the human
7/18/17 - Congressmen Marino and Cicilline Applaud FDA's Public Meeting on Generic Drug Pricing
Washington, D.C. Today, the U.S. Food and Drug Administration held a public meeting to solicit input in areas where the FDA's rules are being used in ways that create obstacles and delays. Commissioner Gottlieb commented last week that the FDA has seen problems with branded pharmaceutical companies using the Risk Evaluation and Mitigation Strateg
7/18/17 - Drug Discount Program Vital to Cancer Patients
Unfortunately, the pharmaceutical industry is working hard in Washington to gut it. Congress created the program in 1992 with bipartisan support to allow health providers that serve large numbers of low-income patients to receive discounted medications from drug companies. A course of Omacetaxine for leukemia costs $176,000 per year.
7/18/17 - European Commission Sends Statement of Objections to Teva on Pay for Delay Pharma Agreement
The European Commission has informed pharmaceutical company Teva of its preliminary view that an agreement concluded with Cephalon was in breach of European Union (EU) antitrust rules. Under the agreement, Teva committed not to market a cheaper generic version of Cephalon's drug for sleep disorders, modafinil.
7/18/17 - FDA approves Vosevi for Hepatitis C
The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus genotypes 1-6 without cirrhosis or with mild cirrhosis. Vosevi provides a treatment option for some patients who were not successfully treated with other HCV drugs in the past, "said Edward Cox, M.D., director of the Office of Antimicrobial Pr
7/18/17 - Findings from Thomas Jefferson University Provides New Data on Clinical Trials and Studies (Subharmonic and Endoscopic Contrast Imaging of Pancreatic...
By a News Reporter-Staff News Editor at China Weekly News Investigators publish new report on Clinical Research- Clinical Trials and Studies. According to news reporting originating from Philadelphia, Pennsylvania, by VerticalNews correspondents, research stated, "To use subharmonic imaging to depict the vascularity of pancreatic masses compared
7/18/17 - Former President Of Fort Myers Dietary Supplement Company Sentenced To Prison For Misbranded Food
District Judge Sheri Polster Chappell has sentenced Derek Vest to 18 months in federal prison for introducing misbranded food into interstate commerce. According to court documents, from at least April 16, 2013, through November 28, 2014, Vest was the President of Gentech Pharmaceutical, a dietary supplement sales, marketing, and distribution facil
7/18/17 - Hospira, Inc. et al.; Withdrawal of Approval of 44 New Drug Applications and 158 Abbreviated New Drug Applications; Correction
SUMMARY: The Food and Drug Administration is correcting a notice that appeared in the Federal Register of October 4, 2016. The document inadvertently announced withdrawal of approval for the following two ANDAs: ANDA 074123 for Pindolol Tablets, held by G&W Laboratories, Inc., 111 Coolidge St., South Plainfield, NJ 07080; and ANDA 080828 for Hydroc
7/18/17 - House Energy and Commerce Subcommittee on Oversight and Investigations Hearing
Testimony by Krista Pedley, Director, Office of Pharmacy Affairs, Health Resources and Services Administration, U.S. Department of Health and Human Services. Good morning Chairman Murphy, Ranking Member DeGette and Members of the Subcommittee. My name is CAPT Krista Pedley and I am the Director of the Office of Pharmacy Affairs, within the Health R
7/18/17 - House Financial Services Subcommittee on Capital Markets Hearing
Good morning Chairman Huizenga, Ranking Member Maloney, and Members of the Subcommittee. My name is John Blake, and I am the Senior Vice President of Finance at aTyr Pharma, a clinical-stage biotech company based in San Diego, California. The Biotechnology Innovation Organization represents aTyr and over 1,100 other innovative companies making simi
7/18/17 - How much vitamin D do you need?
Studies show that, while most Americans do not get enough vitamin D, a growing portion of people get too much. Finding a happy medium does not have to be tricky. Khosla is an endocrinologist at Mayo Clinic and says exposure to sunlight is the easiest way to get vitamin D. He says, generally, 30 minutes a day does the trick.
7/18/17 - Korean IVD startup NGeneBio receives CE-IVD mark for next generation sequencing-based BRCA 1/2 test panel and clinical analysis software
By a News Reporter-Staff News Editor at China Weekly News Molecular diagnostics startup NGeneBio Co., Ltd. of Korea has received CE-marking for next generation sequencing- based in vitro diagnostics products, BRCAaccuTestTM and clinical analysis software, NGeneAnalySysTM for hereditary breast/ovarian cancer genetic testing. The company is...
7/18/17 - Morgans rates IDT as Downgrade to Reduce from Add
Dr Paul MacLeman joined IDT in 2013 to turn around the business and acquired a portfolio of 23 generic drugs planned for manufacture and US distribution. Little progress left investors frustrated and now MacLeman has resigned. His resignation leaves the company's generic drug strategy under a cloud, the broker suggests.
7/18/17 - New brain cancer drug targets revealed
By a News Reporter-Staff News Editor at Cancer Weekly Researchers from Case Western Reserve University School of Medicine and The Cleveland Clinic designed a way to screen brain tumor cells and identify potential drug targets missed by other methods. "The genes needed for cancer cells to survive in a tumor were not necessarily the same ones need
7/18/17 - New HIV drug for Nigeria [Sun, The (Nigeria)]
it is heartwarming that a generic version of the most advanced drug for the treatment of Human Immuno-deficiency Virus is to be introduced in Nigeria before the end of the year. With this development, the drug, Dolutegravir which is used in many advanced countries, but not in Africa because of the high cost, will be introduced in Nigeria and Uganda
7/18/17 - On the opioids offensive
On Monday, the Food and Drug Administration said it will require drug manufacturers to better educate physicians about the painkillers. On Tuesday, the Justice Department announced a $35 million settlement with Mallinckrodt Pharmaceuticals, a company charged with looking the other way when it had reason to believe some of its opioids were landing o
7/18/17 - Opioids under attack: Government now on offense
On July 10, the Food and Drug Administration said it will require drug manufacturers to better educate physicians about the painkillers. On July 11, the Justice Department announced a $35 million settlement with Mallinckrodt Pharmaceuticals, a company charged with looking the other way when it had reason to believe some of its opioids were landing
7/18/17 - Panel calls on FDA to review safety of opioids
It urges the FDA to bolster a public health approach that already has resulted in one painkiller being pulled from the market. Last week, the maker of opioid painkiller Opana ER withdrew its drug at the FDA's request following a 2015 outbreak of HIV and hepatitis C in southern Indiana linked to sharing needles to inject the pills. Aaron Kesselheim
7/18/17 - Patent Issued for Antigen-Binding Proteins Comprising Recombinant Protein Scaffolds (USPTO 9695252)
By a News Reporter-Staff News Editor at Life Science Weekly A patent by the inventors Greene, Mark I.; Zhang, Hongtao; Song, Xiaomin; Murali, Ramachandran; Tone, Masahide, filed on April 2, 2014, was published online on July 4, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9695252
7/18/17 - Patent Issued for Magnetic Resonance Imaging and Positron Emission Tomography System (USPTO 9696398)
By a News Reporter-Staff News Editor at Electronics Newsweekly From Alexandria, Virginia, VerticalNews journalists report that a patent by the inventors Ryu, Yeun-chul; Song, Tae-yong; Kim, Young-beom; Yi, Jae-mock; Lee, Seong-deok, filed on November 5, 2013, was published online on July 4, 2017. The patent's assignee for patent number 9696398 is
7/18/17 - Philly biotech's first-ever gene therapy progresses with FDA [Philly.com]
July 17 Philadelphia drug developer Spark Therapeutics said Monday that the Food and Drug Administration has accepted its biologics license application and granted "priority review" for its lead drug candidate to treat rare inherited blindness. It has been granted priority review by the FDA because it treats a medical condition where "no adequate
7/18/17 - Reports from Department of Orthopedics Add New Data to Findings in Drug Delivery Systems (Microwave-assisted Diels-Alder reaction for rapid synthesis...
According to news reporting originating in Shandong, People's Republic of China, by VerticalNews journalists, research stated, "Fluorescent nanodiamond has received increasing research interests for bioimaging and drug delivery owing its outstanding physicochemical properties and low toxicity. Funders for this research include National Science...
7/18/17 - Researchers Submit Patent Application, "Compounds for Inhibition of Fungal Toxin Production", for Approval (USPTO 20170183309)
By a News Reporter-Staff News Editor at Life Science Weekly From Washington, D.C., NewsRx journalists report that a patent application by the inventors Trail, Frances; Jones, A. Daniel, filed on June 5, 2015, was made available online on July 6, 2017. The FDA limits aflatoxin levels in food and feed to 20 ppb, due to its carcinogenic capabilities
7/18/17 - Senate Subcommittee Approves FY2018 Agriculture Appropriations Bill
WASHINGTON, D.C.- The Senate Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies today approved a $145.4 billion appropriations bill to support federal agriculture and nutrition programs in FY2018. The FY2018 Agriculture, Rural Development, Food and Drug Administration, and Related Agenc
7/18/17 - Studies from Soochow University Describe New Findings in Drug Delivery Systems (Redox-Sensitive Nanoscale Coordination Polymers for Drug Delivery and...
By a News Reporter-Staff News Editor at Cancer Weekly Research findings on Drugs and Therapies- Drug Delivery Systems are discussed in a new report. According to news reporting from Jiangsu, People's Republic of China, by NewsRx journalists, research stated, "Nanoscale coordination polymers, with inherent biodegradability, chemical diversities, a
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415